Generic diabetes, cholesterol drugs recalled over safety concerns

Sun Pharmaceutical Industries has recalled 2,528 bottles of its metformin hydrochloride extended release tablets following a complaint indicating the presence of the seizure drug gabapentin in a bottle. Ranbaxy Laboratories has issued a recall of 64,626 bottles of its generic atorvastatin after a...

Share

This news summary appeared in DiabetesPro SmartBrief on 03/11/2014
Click here to view the full issue.


View the original article:
Bloomberg

Want to see more news summaries?
Sign up for DiabetesPro SmartBrief

DiabetesPro SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news summaries like the one to the left
Sign up:
About SmartBrief
SmartBrief is the leading online publisher of targeted business news and information by industry. By combining technology and editorial expertise, SmartBrief filters thousands of sources daily to deliver the most relevant industry news in partnership with more than 180 trade associations, professional societies nonprofits and corporate entities